Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.
Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Pregnancies resulting from assisted reproductive technology (ART) have a higher prevalence of exposure to teratogenic medicines.